Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Edwards Lifesciences Corp
Last earnings -2.2% on 2026-04-23
Revenue grew 11.5% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Edwards Lifesciences Corp shows $6.07B in FY2025 revenue (+11.5% YoY), a 17.7% net margin, and 10.4% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001099800, latest 10-Q filed 2026-05-06) · EODHD · rules-based read · as of 6/17/2026, 7:25:57 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $5.23B | $4.46B | $5.01B | $5.44B | $6.07B |
| Gross profit | $3.98B | $3.74B | $4.03B | $4.32B | $4.73B |
| Operating income | $1.69B | $1.50B | $1.31B | $1.38B | $1.26B |
| Net income | $1.50B | $1.52B | $1.40B | $4.17B | $1.07B |
| Diluted EPS | $2.38 | $2.44 | $2.30 | $6.97 | $1.83 |
| Net margin | 28.7% | 34.1% | 28.0% | 76.7% | 17.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Last 90 days: 0 open-market buys · 8 sales
| 2026-05-29 | Dahl Andrew M. SVP, Corporate Controller | Sell | 567.53 @ $86.08 | $48.9K |
| 2026-05-27 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sell | 23.1K @ $86.42 | $2.00M |
| 2026-05-22 | Chopra Daveen CVP, TMTT & Surgical | Sell | 1.50K @ $84.60 | $127K |
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Exercise | 620.00 @ $72.68 | $45.1K |
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Sell | 620.00 @ $81.14 | $50.3K |
| 2026-05-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sell | 9.97K @ $82.07 | $818K |
| 2026-05-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sell | 8.00K @ $81.82 | $655K |
| 2026-05-12 | Zovighian Bernard J CEO | Gift | 26.6K | |
| 2026-05-12 | Zovighian Bernard J CEO | Gift | 26.6K | |
| 2026-05-12 | Zovighian Bernard J CEO | Sell | 845.00 @ $78.40 | $66.3K |
| 2026-05-12 | Zovighian Bernard J CEO | Sell | 35.5K @ $77.92 | $2.77M |
| 2026-05-11 | Zovighian Bernard J CEO | Exercise | 47.2K |